Nmedis sp. z o.o.

Rzeszów, Rzeszów 35-323

1 studies enrolling now · 1 studies all time

What they study most

Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis — Recruiting now